Clinical Report: First European Cases of Robotic Single-Port Vaginal Hysterectomy
Overview
This report details the first successful robotic-assisted vaginal hysterectomy using the da Vinci® Single-Port system in Europe. The procedure demonstrated feasibility and provided insights into surgical techniques and short-term outcomes.
Background
Hysterectomy is a common gynecological procedure, with the vaginal route being the gold standard when possible. The advent of vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) has improved minimally invasive options, yet challenges remain, particularly for larger uterine volumes. Robotic assistance via the Single-Port system may enhance the feasibility and outcomes of vaginal hysterectomy.
Data Highlights
No numerical data was provided in the article.
Key Findings
The first robotic-assisted vaginal hysterectomy using the da Vinci® Single-Port system was performed in Europe on October 23, 2024.
The patient was a 42-year-old woman with a 12 cm anterior fibroid and no previous surgical history.
Robotic assistance facilitated the procedure, allowing for optimal access and visualization.
The total weight of the extracted uterus was 800 g, indicating the capability to manage larger uterine volumes.
Short-term postoperative outcomes were reported, though specific data were not detailed in the article.
Clinical Implications
The integration of robotic assistance in vaginal hysterectomy may expand the indications for this approach, particularly for patients with larger uterine sizes. Surgeons should consider the potential benefits of robotic systems in enhancing surgical precision and patient outcomes.
Conclusion
The successful implementation of robotic single-port vaginal hysterectomy represents a promising advancement in minimally invasive gynecological surgery. Further studies are needed to evaluate long-term outcomes and compare them with traditional approaches.
Meta-analysis of OCT and OCT angiography studies found thicker retinal nerve fiber layers and slightly thinner central macula in patients with polycystic ovary syndrome.